non stemi or stemi case study - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerotic plaque rupture leads to thrombus formation in coronary arteries, causing partial (NSTEMI) or complete (STEMI) blockage, reducing myocardial blood flow and oxygen supply.

• Secondary mechanism: The ischemic myocardial tissue releases troponins and other biomarkers due to cell injury, which can be detected in the blood, confirming myocardial infarction.

• Key complication: Persistent ischemia can lead to myocardial necrosis, impairing heart function and potentially resulting in heart failure or life-threatening arrhythmias if not promptly managed.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, type 2 diabetes, hyperlipidemia

• Current medications: Lisinopril 20 mg daily, Metformin 1000 mg twice daily, Atorvastatin 40 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain

• Key symptoms: Central chest pain radiating to the left arm, shortness of breath, nausea, and diaphoresis

• Vital signs: Blood pressure 150/95 mmHg, heart rate 104 bpm, respiratory rate 22 breaths/min, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the emergency department team conducts an initial assessment of the 56-year-old male patient, further evaluation of his clinical status reveals concerning findings. The patient's ECG shows ST-segment depression in leads V2-V4, consistent with an NSTEMI. Blood tests indicate elevated cardiac biomarkers, with troponin I levels significantly above the normal range at 5.2 ng/mL, reinforcing the diagnosis of myocardial ischemia. Despite being on aspirin therapy, the patient's platelet aggregation appears heightened, suggesting increased thrombus formation risk.

During the assessment, his oxygen saturation drops to 89% on room air, necessitating supplemental oxygen via nasal cannula, which improves saturation to 95%. The patient's breath sounds are clear bilaterally, but he continues to exhibit tachycardia, with a heart rate now climbing to 110 bpm. His blood pressure remains elevated at 152/98 mmHg, indicating ongoing sympathetic nervous system activation. The patient reports worsening of chest pain intensity, rated at 8/10, and increasing nausea, prompting the administration of nitroglycerin and an antiemetic, which provide some symptomatic relief.

As the team reviews the initial management plan, they consider the potential for further complications such as heart failure or arrhythmias. Continuous cardiac monitoring is initiated to promptly detect any changes in rhythm. The patient's risk factors, including hypertension, diabetes, and hyperlipidemia, are noted as contributing to his current condition, necessitating a comprehensive approach to prevent additional cardiac events. With ongoing chest pain and elevated risk, the decision is made to prepare the patient for possible percutaneous coronary intervention (PCI) to restore coronary blood flow and prevent further myocardial damage.

Section 2

As the emergency department team continues to monitor the patient, a change in his clinical status becomes apparent. Approximately one hour after initiating supplemental oxygen and administering nitroglycerin, the patient experiences a sudden increase in chest pain, now rated at 9/10, accompanied by new-onset diaphoresis. His heart rate accelerates further to 120 bpm, and his blood pressure drops to 138/85 mmHg, suggesting a potential decrease in cardiac output. The cardiac monitor reveals the development of frequent premature ventricular contractions (PVCs), raising concerns about the possibility of more significant arrhythmias, such as ventricular tachycardia.

The team quickly reassesses the patient's condition, considering the need for further diagnostic testing to evaluate the extent of myocardial damage and the presence of any new complications. An urgent repeat ECG is ordered, which now shows increasing ST-segment depression in leads V2-V4 and the appearance of T-wave inversions, indicating worsening myocardial ischemia. Concurrently, a second set of blood tests reveals a rise in troponin I levels to 7.8 ng/mL, confirming ongoing myocardial injury.

Given the patient's deteriorating status and the growing evidence of cardiac instability, the decision is made to expedite his transfer to the cardiac catheterization lab for percutaneous coronary intervention (PCI). This urgent intervention aims to reestablish coronary perfusion and mitigate further myocardial damage. In preparation for the procedure, the patient is started on a continuous infusion of heparin to reduce the risk of thrombus propagation, and an intravenous beta-blocker is administered to manage his tachycardia and hypertension. The team remains vigilant, recognizing the need for continuous monitoring and swift intervention to address potential complications such as heart failure or life-threatening arrhythmias as the patient progresses through his acute coronary syndrome.

Section 3

As the patient is prepared for transfer to the cardiac catheterization lab, the team conducts a thorough initial assessment to ensure stability during transport. Despite the interventions, his chest pain persists at 8/10, and he remains diaphoretic, suggesting ongoing ischemic stress. His heart rate stabilizes slightly at 110 bpm following the administration of the beta-blocker, yet his blood pressure shows further decline to 130/80 mmHg, indicating a potential need for inotropic support if hypotension worsens. Auscultation of the lungs reveals new bilateral crackles at the bases, raising the suspicion of early pulmonary congestion, possibly signaling evolving heart failure.

In the catheterization lab, angiography reveals a critical stenosis of 90% in the proximal left anterior descending artery, confirming the need for immediate PCI. During the procedure, the patient develops a transient episode of ventricular tachycardia, which resolves spontaneously, yet highlights the precarious nature of his cardiac status. The interventional cardiologist successfully places a drug-eluting stent, restoring adequate blood flow and improving myocardial perfusion.

Post-procedure, the patient's chest pain diminishes significantly to 3/10, and his diaphoresis subsides, indicating a positive response to the intervention. However, his respiratory status requires close monitoring, as the crackles persist, and his oxygen saturation dips to 92% on room air. A repeat echocardiogram is planned to assess left ventricular function and guide further therapeutic decisions. The team remains vigilant for signs of heart failure exacerbation or recurrent arrhythmias, prepared to adjust the therapeutic approach as needed based on evolving clinical findings.

Section 4

As the patient is carefully monitored post-procedure, the team notes a subtle yet concerning change in his status. Approximately two hours after the PCI, his respiratory rate increases to 24 breaths per minute, and he reports a new sensation of shortness of breath. Oxygen saturation remains at 92% despite supplemental oxygen via nasal cannula at 2 liters per minute. The persistence of bilateral crackles upon auscultation, coupled with the increased respiratory effort, prompts the team to consider the development of acute decompensated heart failure.

To gain further insight into the patient's condition, a STAT chest X-ray is ordered, revealing pulmonary edema, corroborating the clinical suspicion of fluid overload. Concurrently, laboratory results show a rising B-type natriuretic peptide (BNP) level of 600 pg/mL, further supporting a diagnosis of heart failure exacerbation. Despite the successful PCI, the patient's left ventricular function is likely compromised, necessitating immediate therapeutic adjustments to manage the fluid status and prevent further deterioration.

In response to these findings, the medical team initiates intravenous diuretics to alleviate pulmonary congestion and closely monitors the patient's vital signs and urine output. The decision is made to repeat the echocardiogram, not only to assess the ejection fraction but also to evaluate for any potential valvular abnormalities that could exacerbate his condition. As the patient receives these interventions, the team remains vigilant for any signs of hemodynamic instability or arrhythmic events, ready to escalate care promptly if new complications arise. The clinical picture underscores the importance of dynamic reassessment and the need for a multi-faceted approach to address both ischemic and heart failure components of the patient's complex presentation.

Section 5

Despite the team's proactive management, the patient's condition continues to evolve. Approximately four hours post-PCI, the patient exhibits a further change in status. His blood pressure drops to 90/58 mmHg, and he becomes increasingly lethargic, with a heart rate now at 118 beats per minute. The team quickly reassesses the patient, noting that he is diaphoretic and his skin is cool to the touch. These findings raise concerns about potential cardiogenic shock, a recognized complication in the context of acute decompensated heart failure following myocardial ischemia.

In light of these concerning developments, the medical team orders additional laboratory tests and a repeat electrocardiogram. The laboratory results reveal a further increase in serum lactate levels to 3.5 mmol/L, suggesting impaired tissue perfusion. The ECG, while not demonstrating any new ischemic changes, shows sinus tachycardia, consistent with the patient's compensatory response to reduced cardiac output. In consideration of these findings, the decision is made to initiate inotropic support with dobutamine to enhance myocardial contractility and improve perfusion, while continuing diuretic therapy to manage fluid overload.

As the interventions are implemented, the team maintains a keen focus on monitoring the patient's hemodynamic parameters and organ function. They are prepared to escalate care, potentially involving the initiation of mechanical circulatory support, should the patient's condition fail to stabilize. This ongoing situation emphasizes the critical importance of integrating clinical reasoning with rapid decision-making, balancing the immediate need to support cardiac function while minimizing the risk of further complications. The unfolding clinical scenario remains fluid, requiring constant vigilance and adaptability to navigate the patient's complex medical landscape.